Your browser doesn't support javascript.
loading
Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer.
Lukovic, Jelena; Hosni, Ali; Liu, Amy; Chen, Jasmine; Tadic, Tony; Patel, Tirth; Li, Kecheng; Han, Kathy; Lindsay, Patricia; Craig, Tim; Brierley, James; Barry, Aisling; Wong, Rebecca; Ringash, Jolie; Dawson, Laura A; Kim, John J.
Afiliação
  • Lukovic J; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Electronic address: Jelena.lukovic@rmp.uhn.ca.
  • Hosni A; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Liu A; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Electronic address: zhihuiamy.liu@uhnresearch.ca.
  • Chen J; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
  • Tadic T; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Patel T; Techna Institute, Toronto, ON, Canada.
  • Li K; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Han K; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Lindsay P; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Craig T; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Brierley J; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Barry A; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Wong R; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Ringash J; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Dawson LA; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Kim JJ; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Radiother Oncol ; 178: 109429, 2023 01.
Article em En | MEDLINE | ID: mdl-36455685

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Ânus / Dermatite / Radioterapia de Intensidade Modulada Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Ânus / Dermatite / Radioterapia de Intensidade Modulada Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Radiother Oncol Ano de publicação: 2023 Tipo de documento: Article